Concepedia

Kou Hioki

KH

6

Publications

103

Citations

6

H-Index

2020

Active since

Affiliations

The University of Tokyo(Current)

The University of Osaka

National Institute of Biomedical Innovation, Health and Nutrition

Hyogo Medical University

Kou Hioki is an author at The University of Tokyo specializing in innate immunity, t cell immunity, and broad-spectrum vaccines.

ORCID

Top concepts

Publications per year

2020–2024

6

Publications

6

Anti-tumor immunity by transcriptional synergy between TLR9 and STING activation

Burcu Temizoz, Kou Hioki, Shingo Kobari et al. · International Immunology · 2022 · 25 citations

5,6-dimethylxanthenone-4-acetic acid (DMXAA), a partial STING agonist, competes for human STING activation

Burcu Temizoz, Takayuki Shibahara, Kou Hioki et al. · Frontiers in Immunology · 2024 · 22 citations · Full text

Discovery of Self‐Assembling Small Molecules as Vaccine Adjuvants

Shuyu Jin, Huệ Thị Vũ, Kou Hioki et al. · Angewandte Chemie International Edition · 2020 · 15 citations

TLR9 plus STING Agonist Adjuvant Combination Induces Potent Neopeptide T Cell Immunity and Improves Immune Checkpoint Blockade Efficacy in a Tumor Model

Melisa D. Castro Eiro, Kou Hioki, Ling Li et al. · The Journal of Immunology · 2023 · 15 citations · Full text

Optimization of an LNP-mRNA vaccine candidate targeting SARS-CoV-2 receptor-binding domain

Kouji Kobiyama, Masaki Imai, Nao Jounai et al. · 2021 · 13 citations · Full text

, , +18

Rows per page

1–5 of 6